BROOKE BOYD: Open Payments
NPI 1871063701 · LISBON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 49 payments from 12 companies in 2025. Trend: 2023 $614 · 2024 $1,112 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $261 |
| Lilly USA, LLC | 9 | $195 |
| ABBVIE INC. | 9 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $59 |
| Verona Pharma, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $20 |
Products named: BREZTRI, TALTZ, MOUNJARO, VRAYLAR, CAPLYTA, AIRSUPRA, TRELEGY ELLIPTA, UBRELVY.
Industry payments across OH — which companies pay providers there.
